Lonza Group (LZAGY) Stock Price, News & Analysis

Company Overview

Lonza Group AG is a Switzerland-based life sciences company that provides contract development and manufacturing services to pharmaceutical and biotechnology companies. Its work supports the development and commercial production of medicines, from early-stage research and process development through manufacturing.

The company’s capabilities include biologics, small-molecule medicines and specialized therapies such as cell and gene treatments. Lonza also supplies related technologies, development services and manufacturing expertise to help customers produce complex therapies and pharmaceutical ingredients.

Founded in Switzerland in 1897, Lonza has grown into a global business serving customers across major pharmaceutical and biotechnology markets. Its international network of research, development and manufacturing facilities supports customers seeking production and technical services in multiple regions.

Key Stats

• Today's Range: $79.32 to $79.60
• 50-Day Range: $65.06 to $81.90
• 52-Week Range: $58.53 to $82.63
• Volume: 3,924 shs
• Average Volume: 66,732 shs
• Market Capitalization: $55.74 billion
• P/E Ratio: N/A
• Dividend Yield: 0.18%
• Price Target: N/A
• Consensus Rating: Moderate Buy

Lonza Group Stock Analysis - MarketRank™

Lonza Group scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Lonza Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Lonza Group has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 22.42%

Earnings Growth

Earnings for Lonza Group are expected to grow by 22.42% in the coming year, from $2.23 to $2.73 per share.

Price to Earnings Growth Ratio

Lonza Group has a PEG Ratio of 1.51. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Lonza Group has a P/B Ratio of 5.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of Lonza Group has been sold short.

Short Interest Ratio / Days to Cover

Lonza Group has a short interest ratio ("days to cover") of 0.81, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Lonza Group has recently increased by 59.83%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Lonza Group has a dividend yield of 0.18%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Lonza Group does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Lonza Group will have a dividend payout ratio of 5.13% next year. This indicates that Lonza Group will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.9 / 5
• News Sentiment: -0.50

News Sentiment

Lonza Group has a news sentiment score of -0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Lonza Group this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Lonza Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

0.07% of the stock of Lonza Group is held by insiders.

Percentage Held by Institutions

0.04% of the stock of Lonza Group is held by institutions.

Company Calendar

• Today: 11/12/2026
• Fiscal Year End: 12/31/2026
• Next Earnings (Estimated): 1/27/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:LZAGY
• CIK: 1446711
• Web: www.lonza.com
• Phone: (161) 316-8111
• Fax: 41-61-316-9111
• Employees: 16,866
• Year Founded: 1897

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 29.10
• P/E Growth: 1.51
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.42
• Current Ratio: 1.66
• Quick Ratio: 1.21

Sales & Book Value

• Annual Sales: $7.88 billion
• Price / Sales: 7.08
• Cash Flow: $2.35 per share
• Price / Cash Flow: 33.74
• Book Value: $13.69 per share
• Price / Book: 5.80

Miscellaneous

• Outstanding Shares: 702,290,000
• Free Float: 701,798,000
• Market Cap: $55.80 billion
• Optionable: Not Optionable
• Beta: 1.03